Anti-ARA9 antibody - Carboxyterminal end (ab62813)


  • Product nameAnti-ARA9 antibody - Carboxyterminal end
    See all ARA9 primary antibodies
  • Description
    Goat polyclonal to ARA9 - Carboxyterminal end
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Mouse
    Predicted to work with: Rat, Horse, Cow, Human
  • Immunogen

    Synthetic peptide:


    , corresponding to C terminal amino acids 310-323 of Human ARA9

  • Positive control
    • NIH 3T3 cell lysates.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris buffered saline, pH 7.3
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesab62813 is purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab62813 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesPeptide ELISA: 1/64000.
    WB: Use at a concentration of 0.02 - 0.06 µg/ml. Detects a band of approximately 37 kDa (predicted molecular weight: 40 kDa).

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionMay play a positive role in AHR-mediated (aromatic hydrocarbon receptor) signaling, possibly by influencing its receptivity for ligand and/or its nuclear targeting.
      Cellular negative regulator of the hepatitis B virus (HBV) X protein.
    • Tissue specificityWidely expressed. Higher levels seen in the heart, placenta and skeletal muscle. Not expressed in the liver.
    • Involvement in diseaseDefects in AIP are a cause of familial isolated pituitary adenoma (FIPA) [MIM:102200].
      Defects in AIP are a cause of growth hormone-secreting pituitary adenoma (GHSPA) [MIM:102200]; also known as familial isolated somatotropinomas (FIS) or isolated familial somatotropinoma (IFS) or familial somatotrophinoma or acromegaly due to pituitary adenoma.
      Defects in AIP are a cause of ACTH-secreting pituitary adenoma (ASPA) [MIM:219090]; also known as pituitary Cushing disease. A pituary adenoma resulting in excessive production of adrenocorticotropic hormone. This leads to hypersecretion of cortisol by the adrenal glands and ACTH-dependent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and trunkal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes.
      Defects in AIP are a cause of prolactin-secreting pituitary adenoma (PSPA) [MIM:600634]; also known as prolactinoma. Prolactin-secreting pituitary adenoma is the most common type of hormonally active pituitary adenoma.
    • Sequence similaritiesContains 1 PPIase FKBP-type domain.
      Contains 2 TPR repeats.
    • Cellular localizationCytoplasm.
    • Information by UniProt
    • Database links
    • Alternative names
      • AH receptor interacting protein antibody
      • AH receptor-interacting protein antibody
      • AIP antibody
      • AIP_HUMAN antibody
      • ARA 9 antibody
      • ARA9 antibody
      • Aryl hydrocarbon receptor interacting protein antibody
      • Aryl-hydrocarbon receptor-interacting protein antibody
      • fa03h10 antibody
      • FKBP 16 antibody
      • FKBP 37 antibody
      • FKBP16 antibody
      • FKBP37 antibody
      • HBV X associated protein 2 antibody
      • HBV X associated protein antibody
      • HBV X-associated protein 2 antibody
      • HBVX associated protein antibody
      • Immunophilin homolog ARA 9 antibody
      • Immunophilin homolog ARA9 antibody
      • SMTPHN antibody
      • XAP 2 antibody
      • XAP-2 antibody
      • XAP2 antibody
      see all

    Anti-ARA9 antibody - Carboxyterminal end images

    References for Anti-ARA9 antibody - Carboxyterminal end (ab62813)

    ab62813 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab62813.
    Please use the links above to contact us or submit feedback about this product.